nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—Sodium Tetradecyl Sulfate—Orlistat—type 2 diabetes mellitus	0.246	0.615	CrCrCtD
Sodium lauryl sulfate—ALB—type 2 diabetes mellitus	0.181	1	CbGaD
Sodium lauryl sulfate—Ethanolamine Oleate—Orlistat—type 2 diabetes mellitus	0.154	0.385	CrCrCtD
Sodium lauryl sulfate—ALB—Gliclazide—type 2 diabetes mellitus	0.0607	0.204	CbGbCtD
Sodium lauryl sulfate—ALB—Repaglinide—type 2 diabetes mellitus	0.0571	0.192	CbGbCtD
Sodium lauryl sulfate—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0476	0.16	CbGbCtD
Sodium lauryl sulfate—ALB—Valsartan—type 2 diabetes mellitus	0.0421	0.142	CbGbCtD
Sodium lauryl sulfate—ALB—Nateglinide—type 2 diabetes mellitus	0.0391	0.132	CbGbCtD
Sodium lauryl sulfate—ALB—Glyburide—type 2 diabetes mellitus	0.0264	0.0889	CbGbCtD
Sodium lauryl sulfate—ALB—Losartan—type 2 diabetes mellitus	0.0242	0.0813	CbGbCtD
Sodium lauryl sulfate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00109	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000103	0.00109	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Metformin—type 2 diabetes mellitus	0.000103	0.00108	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000102	0.00108	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Orlistat—type 2 diabetes mellitus	0.000102	0.00108	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00108	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00108	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Valsartan—type 2 diabetes mellitus	0.000102	0.00108	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Glipizide—type 2 diabetes mellitus	0.000102	0.00107	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000101	0.00107	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Valsartan—type 2 diabetes mellitus	0.000101	0.00107	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000101	0.00107	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000101	0.00106	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000101	0.00106	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Orlistat—type 2 diabetes mellitus	0.0001	0.00106	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Orlistat—type 2 diabetes mellitus	0.0001	0.00106	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.00105	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Losartan—type 2 diabetes mellitus	9.91e-05	0.00105	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	9.8e-05	0.00104	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	9.77e-05	0.00103	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Glipizide—type 2 diabetes mellitus	9.76e-05	0.00103	CcSEcCtD
Sodium lauryl sulfate—Syncope—Metformin—type 2 diabetes mellitus	9.76e-05	0.00103	CcSEcCtD
Sodium lauryl sulfate—Oedema—Valsartan—type 2 diabetes mellitus	9.75e-05	0.00103	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	9.75e-05	0.00103	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Pioglitazone—type 2 diabetes mellitus	9.73e-05	0.00103	CcSEcCtD
Sodium lauryl sulfate—Infection—Valsartan—type 2 diabetes mellitus	9.69e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Rash—Glipizide—type 2 diabetes mellitus	9.68e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Glipizide—type 2 diabetes mellitus	9.67e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	9.66e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	9.63e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Oedema—Orlistat—type 2 diabetes mellitus	9.63e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Headache—Glipizide—type 2 diabetes mellitus	9.62e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Metformin—type 2 diabetes mellitus	9.61e-05	0.00102	CcSEcCtD
Sodium lauryl sulfate—Shock—Valsartan—type 2 diabetes mellitus	9.59e-05	0.00101	CcSEcCtD
Sodium lauryl sulfate—Infection—Orlistat—type 2 diabetes mellitus	9.57e-05	0.00101	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Metformin—type 2 diabetes mellitus	9.56e-05	0.00101	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Gliclazide—type 2 diabetes mellitus	9.53e-05	0.00101	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Losartan—type 2 diabetes mellitus	9.52e-05	0.00101	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Glimepiride—type 2 diabetes mellitus	9.48e-05	0.001	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Losartan—type 2 diabetes mellitus	9.46e-05	0.001	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	9.46e-05	0.001	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Sitagliptin—type 2 diabetes mellitus	9.45e-05	0.000999	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Glyburide—type 2 diabetes mellitus	9.39e-05	0.000993	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Glyburide—type 2 diabetes mellitus	9.34e-05	0.000988	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	9.31e-05	0.000985	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Valsartan—type 2 diabetes mellitus	9.29e-05	0.000983	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.27e-05	0.000981	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Metformin—type 2 diabetes mellitus	9.26e-05	0.00098	CcSEcCtD
Sodium lauryl sulfate—Headache—Pioglitazone—type 2 diabetes mellitus	9.22e-05	0.000975	CcSEcCtD
Sodium lauryl sulfate—Syncope—Irbesartan—type 2 diabetes mellitus	9.21e-05	0.000974	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.000968	CcSEcCtD
Sodium lauryl sulfate—Nausea—Glipizide—type 2 diabetes mellitus	9.12e-05	0.000965	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Glimepiride—type 2 diabetes mellitus	9.11e-05	0.000964	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Valsartan—type 2 diabetes mellitus	9.11e-05	0.000964	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Losartan—type 2 diabetes mellitus	9.1e-05	0.000963	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.08e-05	0.000961	CcSEcCtD
Sodium lauryl sulfate—Constipation—Gliclazide—type 2 diabetes mellitus	9.07e-05	0.00096	CcSEcCtD
Sodium lauryl sulfate—Rash—Glimepiride—type 2 diabetes mellitus	9.03e-05	0.000956	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.03e-05	0.000955	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000954	CcSEcCtD
Sodium lauryl sulfate—Rash—Sitagliptin—type 2 diabetes mellitus	9.01e-05	0.000953	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9e-05	0.000952	CcSEcCtD
Sodium lauryl sulfate—Headache—Glimepiride—type 2 diabetes mellitus	8.98e-05	0.00095	CcSEcCtD
Sodium lauryl sulfate—Headache—Sitagliptin—type 2 diabetes mellitus	8.95e-05	0.000947	CcSEcCtD
Sodium lauryl sulfate—Oedema—Metformin—type 2 diabetes mellitus	8.88e-05	0.000939	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.84e-05	0.000936	CcSEcCtD
Sodium lauryl sulfate—Infection—Metformin—type 2 diabetes mellitus	8.82e-05	0.000933	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.75e-05	0.000926	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000924	CcSEcCtD
Sodium lauryl sulfate—Shock—Metformin—type 2 diabetes mellitus	8.73e-05	0.000924	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000921	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.71e-05	0.000921	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.69e-05	0.000919	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.68e-05	0.000918	CcSEcCtD
Sodium lauryl sulfate—Syncope—Losartan—type 2 diabetes mellitus	8.66e-05	0.000916	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.65e-05	0.000915	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.58e-05	0.000908	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.55e-05	0.000904	CcSEcCtD
Sodium lauryl sulfate—Ethanolamine Oleate—CYP2E1—type 2 diabetes mellitus	8.55e-05	1	CrCbGaD
Sodium lauryl sulfate—Palpitations—Losartan—type 2 diabetes mellitus	8.54e-05	0.000903	CcSEcCtD
Sodium lauryl sulfate—Nausea—Glimepiride—type 2 diabetes mellitus	8.51e-05	0.0009	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Ramipril—type 2 diabetes mellitus	8.5e-05	0.000899	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.49e-05	0.000898	CcSEcCtD
Sodium lauryl sulfate—Nausea—Sitagliptin—type 2 diabetes mellitus	8.48e-05	0.000897	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Glyburide—type 2 diabetes mellitus	8.48e-05	0.000897	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.47e-05	0.000896	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Metformin—type 2 diabetes mellitus	8.46e-05	0.000895	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000892	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Valsartan—type 2 diabetes mellitus	8.41e-05	0.000889	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000887	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000887	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.38e-05	0.000886	CcSEcCtD
Sodium lauryl sulfate—Oedema—Irbesartan—type 2 diabetes mellitus	8.38e-05	0.000886	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000886	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Glyburide—type 2 diabetes mellitus	8.36e-05	0.000884	CcSEcCtD
Sodium lauryl sulfate—Constipation—Valsartan—type 2 diabetes mellitus	8.34e-05	0.000882	CcSEcCtD
Sodium lauryl sulfate—Infection—Irbesartan—type 2 diabetes mellitus	8.32e-05	0.00088	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Orlistat—type 2 diabetes mellitus	8.31e-05	0.000879	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Metformin—type 2 diabetes mellitus	8.3e-05	0.000878	CcSEcCtD
Sodium lauryl sulfate—Shock—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000872	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Losartan—type 2 diabetes mellitus	8.23e-05	0.00087	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.22e-05	0.000869	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Losartan—type 2 diabetes mellitus	8.2e-05	0.000867	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000865	CcSEcCtD
Sodium lauryl sulfate—Rash—Bromocriptine—type 2 diabetes mellitus	8.15e-05	0.000862	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.14e-05	0.000861	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000858	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000857	CcSEcCtD
Sodium lauryl sulfate—Headache—Bromocriptine—type 2 diabetes mellitus	8.1e-05	0.000857	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.09e-05	0.000855	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000845	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.97e-05	0.000843	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Metformin—type 2 diabetes mellitus	7.97e-05	0.000843	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Metformin—type 2 diabetes mellitus	7.92e-05	0.000837	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.88e-05	0.000834	CcSEcCtD
Sodium lauryl sulfate—Oedema—Losartan—type 2 diabetes mellitus	7.88e-05	0.000834	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.88e-05	0.000833	CcSEcCtD
Sodium lauryl sulfate—Infection—Losartan—type 2 diabetes mellitus	7.83e-05	0.000829	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000828	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000827	CcSEcCtD
Sodium lauryl sulfate—Shock—Losartan—type 2 diabetes mellitus	7.76e-05	0.000821	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Valsartan—type 2 diabetes mellitus	7.74e-05	0.000819	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Metformin—type 2 diabetes mellitus	7.72e-05	0.000816	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.71e-05	0.000815	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Losartan—type 2 diabetes mellitus	7.7e-05	0.000814	CcSEcCtD
Sodium lauryl sulfate—Nausea—Bromocriptine—type 2 diabetes mellitus	7.68e-05	0.000812	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Metformin—type 2 diabetes mellitus	7.65e-05	0.00081	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Orlistat—type 2 diabetes mellitus	7.65e-05	0.00081	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.62e-05	0.000806	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000806	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000806	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Gliclazide—type 2 diabetes mellitus	7.61e-05	0.000805	CcSEcCtD
Sodium lauryl sulfate—Constipation—Metformin—type 2 diabetes mellitus	7.59e-05	0.000803	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	7.55e-05	0.00275	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—CRP—type 2 diabetes mellitus	7.54e-05	0.00275	CbGpPWpGaD
Sodium lauryl sulfate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000796	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Losartan—type 2 diabetes mellitus	7.52e-05	0.000795	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Glyburide—type 2 diabetes mellitus	7.51e-05	0.000795	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Gliclazide—type 2 diabetes mellitus	7.51e-05	0.000794	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.00079	CcSEcCtD
Sodium lauryl sulfate—Rash—Glyburide—type 2 diabetes mellitus	7.45e-05	0.000788	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Glyburide—type 2 diabetes mellitus	7.44e-05	0.000787	CcSEcCtD
Sodium lauryl sulfate—Syncope—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000786	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	7.42e-05	0.0027	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Glyburide—type 2 diabetes mellitus	7.4e-05	0.000783	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	7.39e-05	0.00269	CbGpPWpGaD
Sodium lauryl sulfate—Hypotension—Losartan—type 2 diabetes mellitus	7.37e-05	0.000779	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	7.33e-05	0.00267	CbGpPWpGaD
Sodium lauryl sulfate—Palpitations—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000774	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—APOA1—type 2 diabetes mellitus	7.3e-05	0.00266	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.00077	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.28e-05	0.00077	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.26e-05	0.000768	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.26e-05	0.000768	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000764	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.18e-05	0.00076	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000759	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—CD36—type 2 diabetes mellitus	7.17e-05	0.00261	CbGpPWpGaD
Sodium lauryl sulfate—Constipation—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.000758	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	7.15e-05	0.0026	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	7.12e-05	0.00259	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000751	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Losartan—type 2 diabetes mellitus	7.08e-05	0.000749	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Metformin—type 2 diabetes mellitus	7.05e-05	0.000746	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000746	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Losartan—type 2 diabetes mellitus	7.03e-05	0.000744	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000743	CcSEcCtD
Sodium lauryl sulfate—Nausea—Glyburide—type 2 diabetes mellitus	7.02e-05	0.000743	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Metformin—type 2 diabetes mellitus	7.02e-05	0.000742	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Gliclazide—type 2 diabetes mellitus	7.02e-05	0.000742	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Valsartan—type 2 diabetes mellitus	6.99e-05	0.00074	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—ICAM1—type 2 diabetes mellitus	6.93e-05	0.00252	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Orlistat—type 2 diabetes mellitus	6.91e-05	0.000731	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Valsartan—type 2 diabetes mellitus	6.9e-05	0.00073	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—GRB14—type 2 diabetes mellitus	6.86e-05	0.0025	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Losartan—type 2 diabetes mellitus	6.85e-05	0.000725	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.85e-05	0.000725	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—CD36—type 2 diabetes mellitus	6.83e-05	0.00249	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	6.83e-05	0.00248	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Orlistat—type 2 diabetes mellitus	6.82e-05	0.000721	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Losartan—type 2 diabetes mellitus	6.8e-05	0.000719	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000715	CcSEcCtD
Sodium lauryl sulfate—Oedema—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000715	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Gliclazide—type 2 diabetes mellitus	6.75e-05	0.000714	CcSEcCtD
Sodium lauryl sulfate—Constipation—Losartan—type 2 diabetes mellitus	6.74e-05	0.000713	CcSEcCtD
Sodium lauryl sulfate—Rash—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000708	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.68e-05	0.000707	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.67e-05	0.000706	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.000704	CcSEcCtD
Sodium lauryl sulfate—Shock—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000704	CcSEcCtD
Sodium lauryl sulfate—Headache—Gliclazide—type 2 diabetes mellitus	6.65e-05	0.000703	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000701	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000701	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000698	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.59e-05	0.000697	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000691	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.45e-05	0.000682	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Valsartan—type 2 diabetes mellitus	6.45e-05	0.000682	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000682	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	6.4e-05	0.00233	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Orlistat—type 2 diabetes mellitus	6.37e-05	0.000674	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Metformin—type 2 diabetes mellitus	6.37e-05	0.000674	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—CALM1—type 2 diabetes mellitus	6.35e-05	0.00231	CbGpPWpGaD
Sodium lauryl sulfate—Hypotension—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000668	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—INS—type 2 diabetes mellitus	6.31e-05	0.0023	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Gliclazide—type 2 diabetes mellitus	6.3e-05	0.000667	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	6.3e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Metformin—type 2 diabetes mellitus	6.28e-05	0.000664	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	6.28e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—Urticaria—Losartan—type 2 diabetes mellitus	6.26e-05	0.000663	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—APOA1—type 2 diabetes mellitus	6.26e-05	0.00228	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	6.24e-05	0.00227	CbGpPWpGaD
Sodium lauryl sulfate—Abdominal pain—Losartan—type 2 diabetes mellitus	6.23e-05	0.000659	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Losartan—type 2 diabetes mellitus	6.23e-05	0.000659	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—CCL2—type 2 diabetes mellitus	6.2e-05	0.00226	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Valsartan—type 2 diabetes mellitus	6.2e-05	0.000656	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000653	CcSEcCtD
Sodium lauryl sulfate—Rash—Valsartan—type 2 diabetes mellitus	6.15e-05	0.00065	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Valsartan—type 2 diabetes mellitus	6.14e-05	0.00065	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Orlistat—type 2 diabetes mellitus	6.13e-05	0.000648	CcSEcCtD
Sodium lauryl sulfate—Headache—Valsartan—type 2 diabetes mellitus	6.11e-05	0.000646	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Metformin—type 2 diabetes mellitus	6.07e-05	0.000643	CcSEcCtD
Sodium lauryl sulfate—Rash—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000643	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000642	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000642	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	6.07e-05	0.00221	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—CALM1—type 2 diabetes mellitus	6.05e-05	0.0022	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Orlistat—type 2 diabetes mellitus	6.04e-05	0.000638	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000638	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000636	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	5.99e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—type 2 diabetes mellitus	5.96e-05	0.00217	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000627	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	5.92e-05	0.00215	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000622	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Metformin—type 2 diabetes mellitus	5.87e-05	0.000621	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000617	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.81e-05	0.000614	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	5.8e-05	0.00211	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	5.79e-05	0.00211	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Valsartan—type 2 diabetes mellitus	5.79e-05	0.000613	CcSEcCtD
Sodium lauryl sulfate—Constipation—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000612	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000606	CcSEcCtD
Sodium lauryl sulfate—Nausea—Orlistat—type 2 diabetes mellitus	5.72e-05	0.000605	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—type 2 diabetes mellitus	5.69e-05	0.00207	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Losartan—type 2 diabetes mellitus	5.66e-05	0.000598	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Metformin—type 2 diabetes mellitus	5.64e-05	0.000597	CcSEcCtD
Sodium lauryl sulfate—Rash—Metformin—type 2 diabetes mellitus	5.6e-05	0.000592	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Metformin—type 2 diabetes mellitus	5.59e-05	0.000592	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Losartan—type 2 diabetes mellitus	5.58e-05	0.00059	CcSEcCtD
Sodium lauryl sulfate—Headache—Metformin—type 2 diabetes mellitus	5.56e-05	0.000588	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.000586	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000585	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	5.51e-05	0.002	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	5.4e-05	0.00196	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Losartan—type 2 diabetes mellitus	5.39e-05	0.000571	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000568	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000565	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000565	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000563	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TRPC6—type 2 diabetes mellitus	5.33e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000559	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000558	CcSEcCtD
Sodium lauryl sulfate—Nausea—Metformin—type 2 diabetes mellitus	5.27e-05	0.000558	CcSEcCtD
Sodium lauryl sulfate—Headache—Irbesartan—type 2 diabetes mellitus	5.25e-05	0.000555	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—IGF1—type 2 diabetes mellitus	5.23e-05	0.0019	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Losartan—type 2 diabetes mellitus	5.21e-05	0.000552	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—RELA—type 2 diabetes mellitus	5.21e-05	0.00189	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	5.05e-05	0.00184	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Losartan—type 2 diabetes mellitus	5.01e-05	0.00053	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	5.01e-05	0.00182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—type 2 diabetes mellitus	4.98e-05	0.00181	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000527	CcSEcCtD
Sodium lauryl sulfate—Nausea—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000526	CcSEcCtD
Sodium lauryl sulfate—Rash—Losartan—type 2 diabetes mellitus	4.97e-05	0.000526	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Losartan—type 2 diabetes mellitus	4.97e-05	0.000525	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—SERPINE1—type 2 diabetes mellitus	4.97e-05	0.00181	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	4.95e-05	0.0018	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Losartan—type 2 diabetes mellitus	4.94e-05	0.000523	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	4.93e-05	0.00179	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000513	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	4.82e-05	0.00175	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.78e-05	0.00174	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.78e-05	0.00174	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000506	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—type 2 diabetes mellitus	4.73e-05	0.00172	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	4.7e-05	0.00171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—ADRA2A—type 2 diabetes mellitus	4.69e-05	0.00171	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Losartan—type 2 diabetes mellitus	4.68e-05	0.000495	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TIMP1—type 2 diabetes mellitus	4.67e-05	0.0017	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000489	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	4.6e-05	0.00167	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	4.6e-05	0.00167	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	4.48e-05	0.00163	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000473	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—NFKB1—type 2 diabetes mellitus	4.39e-05	0.0016	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	4.38e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000455	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	4.28e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	4.28e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	4.28e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	4.27e-05	0.00155	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000451	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000451	CcSEcCtD
Sodium lauryl sulfate—Headache—Ramipril—type 2 diabetes mellitus	4.24e-05	0.000448	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	4.2e-05	0.00153	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	4.2e-05	0.00153	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	4.14e-05	0.00151	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	4.02e-05	0.00146	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000425	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	3.94e-05	0.00143	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	3.91e-05	0.00142	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.9e-05	0.00142	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.9e-05	0.00142	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	3.88e-05	0.00141	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	3.81e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	3.8e-05	0.00138	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.75e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.75e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	3.75e-05	0.00136	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.69e-05	0.00134	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	3.68e-05	0.00134	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	3.61e-05	0.00131	CbGpPWpGaD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	3.52e-05	0.00128	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	3.49e-05	0.00127	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	3.42e-05	0.00124	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	3.41e-05	0.00124	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.41e-05	0.00124	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	3.39e-05	0.00123	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—THBD—type 2 diabetes mellitus	3.35e-05	0.00122	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	3.25e-05	0.00118	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.24e-05	0.00118	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.24e-05	0.00118	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	3.19e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	3.19e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	3.18e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—BHMT—type 2 diabetes mellitus	3.18e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	3.14e-05	0.00114	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	3.08e-05	0.00112	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	2.99e-05	0.00109	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.96e-05	0.00108	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	2.83e-05	0.00103	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	2.82e-05	0.00103	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AANAT—type 2 diabetes mellitus	2.78e-05	0.00101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	2.78e-05	0.00101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	2.78e-05	0.00101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	2.76e-05	0.001	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	2.75e-05	0.000999	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	2.71e-05	0.000987	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—F7—type 2 diabetes mellitus	2.7e-05	0.000982	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	2.65e-05	0.000964	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.64e-05	0.000962	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CDO1—type 2 diabetes mellitus	2.64e-05	0.000959	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPD2—type 2 diabetes mellitus	2.64e-05	0.000959	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.58e-05	0.000937	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.56e-05	0.000934	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.56e-05	0.000932	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AK1—type 2 diabetes mellitus	2.51e-05	0.000915	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.48e-05	0.000904	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.45e-05	0.000891	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.45e-05	0.000891	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	2.42e-05	0.000879	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	2.41e-05	0.000875	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	2.41e-05	0.000875	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.39e-05	0.00087	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.38e-05	0.000865	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.36e-05	0.00086	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	2.32e-05	0.000844	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	2.32e-05	0.000844	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	2.32e-05	0.000844	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	2.32e-05	0.000844	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.31e-05	0.000841	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.27e-05	0.000825	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	2.26e-05	0.000823	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.25e-05	0.000818	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.24e-05	0.000815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ND1—type 2 diabetes mellitus	2.24e-05	0.000815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—G6PC—type 2 diabetes mellitus	2.24e-05	0.000815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HBA2—type 2 diabetes mellitus	2.24e-05	0.000815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	2.24e-05	0.000815	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	2.2e-05	0.000802	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	2.2e-05	0.000801	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	2.19e-05	0.000797	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GCGR—type 2 diabetes mellitus	2.17e-05	0.00079	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	2.16e-05	0.000788	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	2.1e-05	0.000765	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.09e-05	0.00076	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.08e-05	0.000758	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	2.05e-05	0.000746	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYTB—type 2 diabetes mellitus	2.05e-05	0.000746	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	2e-05	0.000727	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.99e-05	0.000723	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.96e-05	0.000714	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.91e-05	0.000693	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.91e-05	0.000693	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.91e-05	0.000693	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.9e-05	0.000693	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.9e-05	0.00069	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1.86e-05	0.000678	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.83e-05	0.000665	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.83e-05	0.000665	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.81e-05	0.000658	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.76e-05	0.00064	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.76e-05	0.00064	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.73e-05	0.000629	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.73e-05	0.000628	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.7e-05	0.000618	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.7e-05	0.000618	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.7e-05	0.000618	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.65e-05	0.000599	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.64e-05	0.000597	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.64e-05	0.000597	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.63e-05	0.000595	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.62e-05	0.00059	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.62e-05	0.000589	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.6e-05	0.000581	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.57e-05	0.000572	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.57e-05	0.00057	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.56e-05	0.000566	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.53e-05	0.000558	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.52e-05	0.000551	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	1.5e-05	0.000544	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HK1—type 2 diabetes mellitus	1.49e-05	0.000544	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.49e-05	0.000543	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.46e-05	0.000532	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	1.45e-05	0.000529	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.44e-05	0.000525	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.44e-05	0.000525	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.44e-05	0.000525	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.44e-05	0.000525	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.43e-05	0.000521	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.39e-05	0.000506	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.39e-05	0.000505	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1.38e-05	0.000504	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	1.36e-05	0.000497	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	1.35e-05	0.000491	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.34e-05	0.000489	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.32e-05	0.00048	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.32e-05	0.000479	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.3e-05	0.000474	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	1.29e-05	0.000468	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.24e-05	0.000451	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.2e-05	0.000437	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.2e-05	0.000435	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.19e-05	0.000435	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.18e-05	0.000428	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.18e-05	0.000428	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.15e-05	0.00042	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.15e-05	0.000418	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.15e-05	0.000417	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.15e-05	0.000417	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.15e-05	0.000417	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.14e-05	0.000415	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.14e-05	0.000413	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.12e-05	0.000407	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.11e-05	0.000403	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.08e-05	0.000395	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.08e-05	0.000395	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.03e-05	0.000374	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.03e-05	0.000374	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.03e-05	0.000374	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.01e-05	0.000368	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1e-05	0.000364	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.87e-06	0.000359	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	9.79e-06	0.000356	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	9.67e-06	0.000352	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	9.41e-06	0.000342	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	9.3e-06	0.000339	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	9.3e-06	0.000339	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	9.07e-06	0.00033	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.03e-06	0.000329	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	8.92e-06	0.000325	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GCG—type 2 diabetes mellitus	8.92e-06	0.000325	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SRC—type 2 diabetes mellitus	8.02e-06	0.000292	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	7.81e-06	0.000284	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GNB3—type 2 diabetes mellitus	7.69e-06	0.00028	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.69e-06	0.00028	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	7.65e-06	0.000279	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CAT—type 2 diabetes mellitus	7.55e-06	0.000275	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—APOB—type 2 diabetes mellitus	7.33e-06	0.000267	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	7.17e-06	0.000261	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	7.13e-06	0.00026	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LPL—type 2 diabetes mellitus	7e-06	0.000255	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	6.85e-06	0.000249	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GPX1—type 2 diabetes mellitus	6.83e-06	0.000249	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CD36—type 2 diabetes mellitus	6.65e-06	0.000242	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	6.57e-06	0.000239	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	6.3e-06	0.000229	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPARA—type 2 diabetes mellitus	6.18e-06	0.000225	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AGT—type 2 diabetes mellitus	5.99e-06	0.000218	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CALM1—type 2 diabetes mellitus	5.89e-06	0.000214	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—APOE—type 2 diabetes mellitus	5.87e-06	0.000214	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—APOA1—type 2 diabetes mellitus	5.8e-06	0.000211	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPARG—type 2 diabetes mellitus	5.11e-06	0.000186	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—INS—type 2 diabetes mellitus	5.01e-06	0.000182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	4.98e-06	0.000181	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	4.4e-06	0.00016	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NOS3—type 2 diabetes mellitus	4.4e-06	0.00016	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	4.02e-06	0.000146	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.02e-06	7.35e-05	CbGpPWpGaD
